Literature DB >> 21898864

Are posttranslational modifications of β2-glycoprotein I markers for thrombotic risk? Are they triggers of autoimmunity?

Michael D Lockshin, Jane E Salmon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21898864      PMCID： PMC3177154          DOI： 10.1002/art.30382

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  9 in total

1.  Moderate versus high-titer persistently anticardiolipin antibody positive patients: are they clinically different and does high-titer anti-beta 2-glycoprotein-I antibody positivity offer additional predictive information?

Authors:  D Erkan; M Barbhaiya; D George; L Sammaritano; Md Lockshin
Journal:  Lupus       Date:  2009-11-24       Impact factor: 2.911

2.  Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome.

Authors:  Zurina Romay-Penabad; Renan Aguilar-Valenzuela; Rolf T Urbanus; Ronald H W M Derksen; Maarten T T Pennings; Elizabeth Papalardo; Tuya Shilagard; Gracie Vargas; Yong Hwang; Philip G de Groot; Silvia S Pierangeli
Journal:  Blood       Date:  2010-11-30       Impact factor: 22.113

3.  Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.

Authors:  Cetin Agar; Gwendolyn M A van Os; Matthias Mörgelin; Richard R Sprenger; J Arnoud Marquart; Rolf T Urbanus; Ronald H W M Derksen; Joost C M Meijers; Philip G de Groot
Journal:  Blood       Date:  2010-05-12       Impact factor: 22.113

4.  Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury.

Authors:  Yiannis Ioannou; Jing-Yun Zhang; Freda H Passam; Soheila Rahgozar; Jian Cheng Qi; Bill Giannakopoulos; Miao Qi; Pei Yu; Demin M Yu; Philip J Hogg; Steven A Krilis
Journal:  Blood       Date:  2010-06-15       Impact factor: 22.113

Review 5.  The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients.

Authors:  Jane E Salmon; Guillermina Girardi; Michael D Lockshin
Journal:  Nat Clin Pract Rheumatol       Date:  2007-03

6.  Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo.

Authors:  Zurina Romay-Penabad; Maria Guadalupe Montiel-Manzano; Tuya Shilagard; Elizabeth Papalardo; Gracie Vargas; Arun B Deora; Michael Wang; Andrew T Jacovina; Ethel Garcia-Latorre; Elba Reyes-Maldonado; Katherine A Hajjar; Silvia S Pierangeli
Journal:  Blood       Date:  2009-07-23       Impact factor: 22.113

7.  Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies.

Authors:  Surya V Seshan; Claus-Werner Franzke; Patricia Redecha; Marc Monestier; Nigel Mackman; Guillermina Girardi
Journal:  Blood       Date:  2009-06-17       Impact factor: 22.113

8.  Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'.

Authors:  R T Urbanus; M T T Pennings; R H W M Derksen; P G de Groot
Journal:  J Thromb Haemost       Date:  2008-05-15       Impact factor: 5.824

9.  Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.

Authors:  Yiannis Ioannou; Jing-Yun Zhang; Miao Qi; Lu Gao; Jian Cheng Qi; De-Min Yu; Herman Lau; Allan D Sturgess; Panayiotis G Vlachoyiannopoulos; Haralampos M Moutsopoulos; Anisur Rahman; Charis Pericleous; Tatsuya Atsumi; Takao Koike; Stephane Heritier; Bill Giannakopoulos; Steven A Krilis
Journal:  Arthritis Rheum       Date:  2011-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.